Gabelli Funds’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Gabelli Funds’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-8,500	Closed	-$458K	–	1167
2017 Q4	$458K	Hold	8,500	–	–	﹤0.01%	1009
2017 Q3	$485K	Hold	8,500	–	–	﹤0.01%	998
2017 Q2	$511K	Buy	+8,500	New	+$484K	﹤0.01%	999

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Gabelli Funds's BIVV Position: Q1 2018 in Review

Gabelli Funds sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 8,500 shares — an estimated $458K sold.

Gabelli Funds first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $511K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Gabelli Funds reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Gabelli Funds sold 8,500 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $458K.
Gabelli Funds first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
Gabelli Funds's Bioverativ Inc. Common Stock position peaked at $511K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Gabelli Funds's 13F filing for Q1 2018, filed 9 May 2018.